Coagulopathy in COVID‐19

The COVID‐19 pandemic has become an urgent issue in every country. Based on recent reports, the most severely ill patients present with coagulopathy, and disseminated intravascular coagulation (DIC)‐like massive intravascular clot formation is frequently seen in this cohort. Therefore, coagulation t...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of thrombosis and haemostasis Vol. 18; no. 9; pp. 2103 - 2109
Main Authors:	Iba, Toshiaki, Levy, Jerrold H., Levi, Marcel, Thachil, Jecko
Format:	Journal Article
Language:	English
Published:	England Elsevier Limited 01.09.2020 John Wiley and Sons Inc
Subjects:	anticoagulant Anticoagulants Antithrombin Biodegradation Blood Coagulation Blood Coagulation Disorders - blood Blood Coagulation Disorders - complications Blood Coagulation Tests Cell death coagulopathy coronavirus COVID-19 COVID-19 - complications COVID-19 - epidemiology Cytokines - metabolism Degradation products Disseminated intravascular coagulation Disseminated Intravascular Coagulation - blood Disseminated Intravascular Coagulation - complications Fibrin Fibrin - chemistry Fibrin Fibrinogen Degradation Products - metabolism Fibrinogen Fibrinogen - chemistry Fibrinolysis Hemorrhage Hemostasis Humans Hypoxia Immune response Inflammation Lung - metabolism Lung - virology Lymphocytes Lymphocytes - metabolism Pandemics Partial Thromboplastin Time Protease Inhibitors Prothrombin Prothrombin Time Review Sepsis Thrombocytopenia Thromboembolism Thromboplastin Thrombosis Thrombosis - metabolism COVID-19 coronavirus anticoagulant coagulopathy disseminated intravascular coagulation
ISSN:	1538-7933, 1538-7836, 1538-7836
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!